Literature DB >> 15089860

Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility.

Mehmet Sait Yucebilgin1, Mustafa Cosan Terek, Aydin Ozsaran, Fuat Akercan, Osman Zekioglu, Ecmel Isik, Yildiz Erhan.   

Abstract

AIM: To determine the effect of paclitaxel and cisplatin in the reduction of primordial follicular reserve in rat.
MATERIAL AND METHODS: Thirty young female rats were divided randomly into three groups of 10 rats each. Paclitaxel 7.5 mg/kg and cisplatin 5 mg/kg were administered intraperitoneally in a single dose sterile technique to paclitaxel (n=10), and cisplatin (n=10) groups, and sterile saline solution was given to a control group (n=10). To assess the effects of chemotherapeutic agents on the primordial follicles, the rats were oophorectomised 7 days after the administration of chemotherapeutic agents. Haematoxylin and eosin staining was used to determine the number of primordial follicles. Primordial follicles were identified by the presence of an oocyte encapsulated partially or completely by a single layer of flattened follicular cells without a theca layer at the ovarian cortex.
RESULTS: The number of primordial follicles in the control group was 23.1 +/- 16.1 follicles. The number of primordial follicles were decreased significantly in both paclitaxel and cisplatin groups compared to control group (10.3 +/- 13.0 and 13.9 +/- 15.2 follicles, respectively) (P=0.001 and P=0.01, respectively). The difference in the number of primordial follicles between the paclitaxel and cisplatin groups was insignificant (P=0.465).
CONCLUSION: The administration of high dose paclitaxel and cisplatin to young rats causes the depletion of primordial follicles. However, no significant difference was observed between the two agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15089860     DOI: 10.1111/j.1479-828X.2004.00143.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  21 in total

1.  Effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial.

Authors:  Guiping Song; Hui Gao; Zhixiang Yuan
Journal:  Med Oncol       Date:  2013-08-01       Impact factor: 3.064

2.  Use of an organotypic mammalian in vitro follicle growth assay to facilitate female reproductive toxicity screening.

Authors:  Yuanming Xu; Francesca E Duncan; Min Xu; Teresa K Woodruff
Journal:  Reprod Fertil Dev       Date:  2015-02-18       Impact factor: 2.311

Review 3.  The capacity of oocytes for DNA repair.

Authors:  Jessica M Stringer; Amy Winship; Seng H Liew; Karla Hutt
Journal:  Cell Mol Life Sci       Date:  2018-05-10       Impact factor: 9.261

Review 4.  Vitrification of embryos and oocytes for fertility preservation in cancer patients.

Authors:  Keiichi Kato
Journal:  Reprod Med Biol       Date:  2016-02-29

5.  Protective effect of bilberry (Vaccinium myrtillus L.) on cisplatin induced ovarian damage in rat.

Authors:  Dilek Pandir; Ozlem Kara; Mustafa Kara
Journal:  Cytotechnology       Date:  2013-08-20       Impact factor: 2.058

Review 6.  Xenobiotic effects on ovarian preantral follicles.

Authors:  Connie J Mark-Kappeler; Patricia B Hoyer; Patrick J Devine
Journal:  Biol Reprod       Date:  2011-06-22       Impact factor: 4.285

Review 7.  Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure.

Authors:  Oldouz Shareghi-Oskoue; Leili Aghebati-Maleki; Mehdi Yousefi
Journal:  Stem Cell Res Ther       Date:  2021-08-11       Impact factor: 8.079

8.  Can Coenzyme Q10 supplementation protect the ovarian reserve against oxidative damage?

Authors:  Pınar Özcan; Cem Fıçıcıoğlu; Ozge Kizilkale; Mert Yesiladali; Olgu Enis Tok; Ferda Ozkan; Mukaddes Esrefoglu
Journal:  J Assist Reprod Genet       Date:  2016-06-03       Impact factor: 3.412

9.  Induction of estrogen-sensitive epithelial cells derived from human-induced pluripotent stem cells to repair ovarian function in a chemotherapy-induced mouse model of premature ovarian failure.

Authors:  Te Liu; Wenxing Qin; Yongyi Huang; Yanhui Zhao; Jiejun Wang
Journal:  DNA Cell Biol       Date:  2013-09-14       Impact factor: 3.311

10.  CD44+/CD105+ human amniotic fluid mesenchymal stem cells survive and proliferate in the ovary long-term in a mouse model of chemotherapy-induced premature ovarian failure.

Authors:  Te Liu; Yongyi Huang; Lihe Guo; Weiwei Cheng; Gang Zou
Journal:  Int J Med Sci       Date:  2012-09-11       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.